At the recent Iowa Pork Congress in Des Moines, we visited with Brett O’Brien, sr. account manager in technical services for Merck Animal Health, about the company’s new Sequivity vaccine technology for pigs.
“(Sequivity)is an RNA particle technology that allows us to offer a rapid and precise response, with a vaccine that be customized for the veterinarians to use, to help tackle flu,” O’Brien says.
Audio: Brett O’Brien
Continue reading An update on Merck’s Sequivity vaccine technology for pigs at Brownfield Ag News.
